Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.

Singh S, Granberg D, Wolin E, Warner R, Sissons M, Kolarova T, Goldstein G, Pavel M, Öberg K, Leyden J.

J Glob Oncol. 2016 Jun 8;3(1):43-53. doi: 10.1200/JGO.2015.002980. eCollection 2017 Feb.

2.

Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.

Wolin EM, Leyden J, Goldstein G, Kolarova T, Hollander R, Warner RRP.

Pancreas. 2017 May/Jun;46(5):639-647. doi: 10.1097/MPA.0000000000000818.

3.

In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response.

Hurvitz SA, Kalous O, Conklin D, Desai AJ, Dering J, Anderson L, O'Brien NA, Kolarova T, Finn RS, Linnartz R, Chen D, Slamon DJ.

Breast Cancer Res Treat. 2015 Feb;149(3):669-80. doi: 10.1007/s10549-015-3282-x. Epub 2015 Feb 8.

PMID:
25663547
4.

[Development of PCR methods and their applications in oncological research and practice].

Hrstka R, Kolářová T, Michalova E, Vojtěšek B.

Klin Onkol. 2014;27 Suppl 1:S69-74. Review. Czech.

PMID:
24945540
5.

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.

Kalous O, Conklin D, Desai AJ, Dering J, Goldstein J, Ginther C, Anderson L, Lu M, Kolarova T, Eckardt MA, Langerød A, Børresen-Dale AL, Slamon DJ, Finn RS.

Breast Cancer Res Treat. 2013 Oct;141(3):397-408. doi: 10.1007/s10549-013-2702-z. Epub 2013 Oct 5.

PMID:
24091768
6.

The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes.

Tomek A, Maťoška V, Kolářová T, Neumann J, Srámek M, Sarbochová I, Táborský L, Bojar M, Goetz P, Serebruany VL.

Cardiology. 2013;125(3):182-91. doi: 10.1159/000350407. Epub 2013 Jun 12.

PMID:
23774101
7.

Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer.

Ihnen M, zu Eulenburg C, Kolarova T, Qi JW, Manivong K, Chalukya M, Dering J, Anderson L, Ginther C, Meuter A, Winterhoff B, Jones S, Velculescu VE, Venkatesan N, Rong HM, Dandekar S, Udar N, Jänicke F, Los G, Slamon DJ, Konecny GE.

Mol Cancer Ther. 2013 Jun;12(6):1002-15. doi: 10.1158/1535-7163.MCT-12-0813. Epub 2013 May 31.

8.

Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.

Konecny GE, Kolarova T, O'Brien NA, Winterhoff B, Yang G, Qi J, Qi Z, Venkatesan N, Ayala R, Luo T, Finn RS, Kristof J, Galderisi C, Porta DG, Anderson L, Shi MM, Yovine A, Slamon DJ.

Mol Cancer Ther. 2013 May;12(5):632-42. doi: 10.1158/1535-7163.MCT-12-0999. Epub 2013 Feb 26.

9.

Rapidly quantifying drug sensitivity of dispersed and clumped breast cancer cells by mass profiling.

Chun J, Zangle TA, Kolarova T, Finn RS, Teitell MA, Reed J.

Analyst. 2012 Dec 7;137(23):5495-8. doi: 10.1039/c2an36058f. Epub 2012 Oct 11.

10.

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.

Konecny GE, Winterhoff B, Kolarova T, Qi J, Manivong K, Dering J, Yang G, Chalukya M, Wang HJ, Anderson L, Kalli KR, Finn RS, Ginther C, Jones S, Velculescu VE, Riehle D, Cliby WA, Randolph S, Koehler M, Hartmann LC, Slamon DJ.

Clin Cancer Res. 2011 Mar 15;17(6):1591-602. doi: 10.1158/1078-0432.CCR-10-2307. Epub 2011 Jan 28.

11.

[Study of the absorption, distribution and elimination of some intravenous anesthetics by labelling them with 113m In].

Atanasov A, Kolarova T, Popova M.

Khirurgiia (Sofiia). 1975;28(2):165-70. Bulgarian. No abstract available.

PMID:
1223421
12.

[Color-scintigraphy of the heart cavities and great vessels].

Bozduganov A, Ignatov A, Kolarova T.

Fortschr Geb Rontgenstr Nuklearmed. 1973;0(0):suppl:264-6. German. No abstract available.

PMID:
4366656
13.

[Comparative studies on the basal metabolism and radioactive 131-I accumulation test in the thyroid gland in patients with thyrotoxicosis].

Tzonev K, Kolarova T, Iliev E.

Folia Med (Plovdiv). 1968;10(6):383-8. French. No abstract available.

PMID:
5006191

Supplemental Content

Loading ...
Support Center